Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents

作者: Valeria Famiglini , Giuseppe La Regina , Antonio Coluccia , Domiziana Masci , Andrea Brancale

DOI: 10.1021/ACS.JMEDCHEM.6B01906

关键词: StereoisomerismEfavirenzChemistryAlanineEnantiomerGlutamate receptorStereochemistryMutantNucleoside Reverse Transcriptase InhibitorStructure–activity relationship

摘要: We designed and synthesized a series of chiral indolyarylsulfones (IASs) as new HIV-1 NNRTIs. The IASs 8–37 showed potent inhibition the WT NL4-3 strain mutant K103N, Y181C, Y188L, K103N–Y181C strains. Six racemic mixtures, 8, 23–25, 31, 33, were separated at semipreparative level into their pure enantiomers. (R)-8 enantiomer bearing (α-methylbenzyl) was superior to (S)-counterpart. IAS derivatives (S) alanine unit, (S)-23, (S,R)-25, (S)-31, (S)-33, remarkably more than corresponding (R)-enantiomers. Compound 23 protected hippocampal neuronal cells from excitotoxic insult, while efavirenz (EFV) did not contrast neurotoxic effect glutamate. present results highlight NNRTIs with improved resistance profile against strains reduced effects.

参考文章(56)
Roger Badia, Judith Grau, Eva Riveira-Muñoz, Ester Ballana, Giuseppe Giannini, José A. Esté, The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent. Antiviral Research. ,vol. 123, pp. 62- 69 ,(2015) , 10.1016/J.ANTIVIRAL.2015.09.004
David B Clifford, HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV medicine : a publication of the International AIDS Society, USA. ,vol. 16, pp. 94- 98 ,(2008)
Ikuo MORIGUCHI, Shuichi HIRONO, Izumi NAKAGOME, Hiroyuki HIRANO, Comparison of Reliability of log P Values for Drugs Calculated by Several Methods Chemical & Pharmaceutical Bulletin. ,vol. 42, pp. 976- 978 ,(1994) , 10.1248/CPB.42.976
Clotilde Lauro, Silvia Di Angelantonio, Raffaela Cipriani, Fabrizia Sobrero, Letizia Antonilli, Valentina Brusadin, Davide Ragozzino, Cristina Limatola, Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons Journal of Immunology. ,vol. 180, pp. 7590- 7596 ,(2008) , 10.4049/JIMMUNOL.180.11.7590
I. C. Anthony, S. N. Ramage, F. W. Carnie, P. Simmonds, J. E. Bell, Influence of HAART on HIV-Related CNS Disease and Neuroinflammation Journal of Neuropathology and Experimental Neurology. ,vol. 64, pp. 529- 536 ,(2005) , 10.1093/JNEN/64.6.529
N. A. C. H. Brabers, H. S. L. M. Nottet, Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. European Journal of Clinical Investigation. ,vol. 36, pp. 447- 458 ,(2006) , 10.1111/J.1365-2362.2006.01657.X
Hassan Pajouhesh, George R. Lenz, Medicinal chemical properties of successful central nervous system drugs. Neurorx. ,vol. 2, pp. 541- 553 ,(2005) , 10.1602/NEURORX.2.4.541
Trevor Hawkins, Understanding and managing the adverse effects of antiretroviral therapy Antiviral Research. ,vol. 85, pp. 201- 209 ,(2010) , 10.1016/J.ANTIVIRAL.2009.10.016
Rino Ragno, Marino Artico, Gabriella De Martino, Giuseppe La Regina, Antonio Coluccia, Alessandra Di Pasquali, Romano Silvestri, Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives. Journal of Medicinal Chemistry. ,vol. 48, pp. 213- 223 ,(2005) , 10.1021/JM040854K